<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04029363</url>
  </required_header>
  <id_info>
    <org_study_id>HL-2018-01-TS Feasibility</org_study_id>
    <nct_id>NCT04029363</nct_id>
  </id_info>
  <brief_title>Feasibility Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk</brief_title>
  <official_title>Feasibility Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HighLife SAS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MedPass International</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>HighLife SAS</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      to evaluate the feasibility, safety and performance of the HighLife 28mm Transcatheter Mitral&#xD;
      Valve in patients with moderate-severe or severe mitral regurgitation who are at high risk&#xD;
      for surgical treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 28, 2019</start_date>
  <completion_date type="Anticipated">July 2025</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Device Safety</measure>
    <time_frame>30 days</time_frame>
    <description>Freedom from major adverse events</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Mitral Regurgitation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HighLife Transcatheter Mitral Valve Replacement</intervention_name>
    <description>Transcatheter Mitral Valve Replacement</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1. Age ≥ 18 years 2. Moderate-severe or severe mitral regurgitation (≥ 3+) 3. Patient&#xD;
             has New York Heart Association (NYHA) Functional Class II, III or ambulatory IV 4.&#xD;
             Patient is under guideline directed medical therapy, as reviewed and confirmed by the&#xD;
             local multidisciplinary Heart Team, for at least one month 5. Patient is high-risk for&#xD;
             open-heart surgery based on the assessment of the multidisciplinary Heart Team using&#xD;
             standard scoring systems and consideration of co-morbidities, frailty, and disability&#xD;
             6. Patient meets the anatomical criteria for HighLife valve 7. Patient is willing to&#xD;
             participate in the study and provides signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Any stroke/TIA within 30 days&#xD;
&#xD;
          2. Severe symptomatic carotid stenosis (&gt; 70% by non-invasive imaging)&#xD;
&#xD;
          3. Active infections requiring antibiotic therapy&#xD;
&#xD;
          4. Active ulcer or gastro-intestinal bleeding in the past 3 months&#xD;
&#xD;
          5. History of bleeding diathesis, coagulopathy or refusal of future blood transfusion&#xD;
&#xD;
          6. Patients in whom TEE is not feasible&#xD;
&#xD;
          7. Patients who are pregnant or lactating, or plan to get pregnant in the next 12 months.&#xD;
&#xD;
          8. Patient is unable to comply with the follow-up schedule and assessments&#xD;
&#xD;
          9. Participation in another clinical investigation at the time of inclusion&#xD;
&#xD;
         10. Patient has known allergies to the device components or contrast medium&#xD;
&#xD;
         11. Patient cannot tolerate anticoagulation or antiplatelet therapy&#xD;
&#xD;
         12. Patients with a life expectancy of less than 12 months due to non-cardiac conditions&#xD;
&#xD;
         13. Patient had permanent pacemaker, or similar device with implantable cardiac leads&#xD;
             (i.e. resynchronization therapy) within the last 3 months&#xD;
&#xD;
             -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Martin Rothman, MD</last_name>
    <phone>+1 707 2177167</phone>
    <email>MRothman@highlifemed.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Vincent's Hospital - Sydney</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Muller, MD</last_name>
      <phone>+61 2 8382 2775</phone>
      <email>dmuller@stvincents.com.au</email>
    </contact>
    <investigator>
      <last_name>David Muller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Wesley Hospital</name>
      <address>
        <city>Auchenflower</city>
        <state>Queensland</state>
        <zip>4066</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Worthley</last_name>
      <phone>+61 412 764 909</phone>
      <email>Sonya.McColl@genesiscare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Andrew's Hospital</name>
      <address>
        <city>Adelaide</city>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Worthley, MD</last_name>
      <phone>+61 412 764 909</phone>
      <email>Sonya.McColl@genesiscare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Warringal Hospital</name>
      <address>
        <city>Heidelberg</city>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Worthley, MD</last_name>
      <phone>+61 412 764 909</phone>
      <email>Sonya.McColl@genesiscare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antony Walton, MD</last_name>
      <phone>+61 414 332 444</phone>
      <email>twalton93@me.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Hospital</name>
      <address>
        <city>Perth</city>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Worthley, MD</last_name>
      <phone>+61 412 764 909</phone>
      <email>Sonya.McColl@genesiscare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Shore Private Hospital</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ravinay Bhindi</last_name>
    </contact>
    <investigator>
      <last_name>Ravinay Bhinddi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AZ Sint-Jan</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan van der Heyden, MD</last_name>
      <phone>+32 5045 2640</phone>
      <email>jan.vanderheyden@azsintjan.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Dubois, MD</last_name>
      <phone>+3216344235</phone>
      <email>christophe.dubois@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Christophe Dubois, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric van Belle</last_name>
    </contact>
    <investigator>
      <last_name>Eric van Belle</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Prive - Jacques Cartier</name>
      <address>
        <city>Massy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Lefevre</last_name>
    </contact>
    <investigator>
      <last_name>Thierry Lefevre</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>European Hospital George Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>5015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Karam, MD</last_name>
      <phone>+33 61 801 0664</phone>
      <email>nicole_karam@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux</name>
      <address>
        <city>Pessac</city>
        <zip>33600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lionel Leroux, MD</last_name>
      <phone>+33 557 656 518</phone>
      <email>lionel.leroux@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume Leurent, MD</last_name>
      <phone>+33 299 28 2505</phone>
      <email>guillaume.leurent@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centr Cardiologiqque du Nord</name>
      <address>
        <city>St. Denis</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Nejjari</last_name>
    </contact>
    <investigator>
      <last_name>Mohammed Nejjari</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinque Pasteur</name>
      <address>
        <city>Toulouse</city>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier Tchetche, MD</last_name>
      <phone>+33 562 211 699</phone>
      <email>dtchetche@clinique-pasteur.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Heart Center Freiburg - Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franz-Josef Neumann, MD</last_name>
      <phone>+4976334022201</phone>
      <email>franzz-josef.neumann@universitaets-hezzentrum.de</email>
    </contact>
    <investigator>
      <last_name>Franz-Josef Neumann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Nickenig, MD</last_name>
      <phone>+4922828715217</phone>
      <email>georg.nickenig@ukbonn.de</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Richter</last_name>
      <phone>+4922828714305</phone>
      <email>jennifer.richter@ukbonn.de</email>
    </contact_backup>
    <investigator>
      <last_name>Georg Nickenig, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heart Center, University Hospital Dresden</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Linke</last_name>
    </contact>
    <investigator>
      <last_name>Axel Linke</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsklink Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edith Lubos, MD</last_name>
      <phone>+49 7410 53977940</phone>
      <email>e.lubos@uke.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herzentrum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Lurz, MD</last_name>
      <phone>+49341865252022</phone>
      <email>philipp.lurz@helios-gesundheit.de</email>
    </contact>
    <investigator>
      <last_name>Philipp Lurz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Rottbauer, MD</last_name>
      <phone>+49 731 500 45000</phone>
      <email>wolfgang.rottbauer@uniklinik-ulm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of Silesia Hospital</name>
      <address>
        <city>Katowice</city>
        <zip>40-635</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wojciech Wojakowski, MD</last_name>
      <phone>+48 604 188 669</phone>
      <email>wwojakowski@sum.edu.pl</email>
    </contact>
    <investigator>
      <last_name>Wojciech Wojakowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Lord's Transfiguration</name>
      <address>
        <city>Poznan</city>
        <zip>61-848</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marek Grygier, MD</last_name>
      <phone>+48 61 854 9228</phone>
      <email>marek.grygier@skpp.edu.pl</email>
    </contact>
    <investigator>
      <last_name>Marek Grygier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zenon Huczek, MD</last_name>
      <phone>+48 692 433 568</phone>
      <email>zhuczek@wp.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology</name>
      <address>
        <city>Warsaw</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Witkowski, MD</last_name>
      <phone>+48 223 43 4127</phone>
      <email>witkowski@hbz.pl</email>
    </contact>
    <investigator>
      <last_name>Adam Witkowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Belfast</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Spence</last_name>
    </contact>
    <investigator>
      <last_name>Mark Spence</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brighton and Sussex University Hospital</name>
      <address>
        <city>Brighton</city>
        <zip>BN2 5BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Hildick-Smith, MD</last_name>
      <phone>+44 1273 696955</phone>
      <phone_ext>7687</phone_ext>
      <email>david.hildick-smith@bsuh.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leeds Teaching Hospitals NHS Trust</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Blackman, MD</last_name>
    </contact>
    <investigator>
      <last_name>Dan Blackman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals of Leicester NHS Trust</name>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Kovac, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jan Kovac</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guy's and St. Thomas' NHS Foundation Trust - St. Thomas Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard Prendergast, MD</last_name>
      <phone>+44 207 188 9435</phone>
      <email>bernard.prendergast@gstt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Radcliffe</name>
      <address>
        <city>Oxford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrian Banning</last_name>
    </contact>
    <investigator>
      <last_name>Adrian Banning</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Poland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>July 20, 2019</study_first_submitted>
  <study_first_submitted_qc>July 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2019</study_first_posted>
  <last_update_submitted>August 25, 2021</last_update_submitted>
  <last_update_submitted_qc>August 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

